Reviewing the Computational Landscape of Drug Repurposing: Evolution from Structure-Based Methods to LLM-Based Methods
Biomolecules · 2026
DOI: 10.3390/biom16060830 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Zengyun Mou und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Artificial Intelligence, Beijing Normal University, Beijing 100088, China. Hauptthemen laut MEDLINE: Drug Repositioning, Computational Biology. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 185 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Ministry of Education of China, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Traditional drug discovery is a high-risk, time-consuming, and costly endeavor. Drug repurposing has emerged as a pivotal strategy to overcome these challenges by identifying new therapeutic indications for approved drugs, thereby significantly reducing development timelines, costs, and safety risks. This review aims to provide a comprehensive methodological survey of computational strategies for drug repurposing. It seeks to clarify the core principles, applicability, and limitations of various approaches, offering a clear technological landscape and valuable insights for future research directions. We categorize and elaborate on the prevailing methodologies, following a logical progression. The review begins with biological mechanism-driven methods, including structure-based, omics-based, fuzzy logic-based, and adverse event-based methods. It then details network-based methods that integrate multi-source data, encompassing graph mining and matrix factorization/completion techniques. Finally, we explore data-driven paradigms, tracing the evolution from traditional text mining-based methods to cutting-edge large language model (LLM)-based methods. Each methodological category presents unique advantages and challenges. While structure-based, omics-based, fuzzy logic-based, and adverse event-based methods provide deep mechanistic insights, network-based methods enable systematic prediction. Text mining unlocks information from vast literature, a potential greatly amplified by LLMs. This review highlights that the future of drug repurposing lies in the intelligent integration of diverse methodologies. In the future, we believe that network-based methods and data-driven methods will mark the beginning of large-scale drug repurposing, but ultimately, biological mechanism-driven methods will still be necessary for rigorous validation and explanation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Artificial Intelligence, Beijing Normal University, Beijing 100088, China.
ORCID-Profile: Zengyun Mou
Förderung
- National Natural Science Foundation of China
- Ministry of Education of China
- Fundamental Research Funds for the Central Universities
- Joint Fund for the Provincial Science and Technology R&D Program of Henan Province
Zitieren
APA
Mou, Z., Tian, Z., Jin, J., Yu, H., & Huang, Y. (2026). Reviewing the Computational Landscape of Drug Repurposing: Evolution from Structure-Based Methods to LLM-Based Methods. Biomolecules. https://doi.org/10.3390/biom16060830
Vancouver
Mou Z, Tian Z, Jin J, Yu H, Huang Y. Reviewing the Computational Landscape of Drug Repurposing: Evolution from Structure-Based Methods to LLM-Based Methods. Biomolecules. 2026. doi:10.3390/biom16060830
BibTeX
@article{Mou2026,
author = {Mou, Zengyun and Tian, Zhiqing and Jin, Jiaqi and Yu, Heng and Huang, Yongzhen},
title = {Reviewing the Computational Landscape of Drug Repurposing: Evolution from Structure-Based Methods to LLM-Based Methods},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16060830}
}
EUVIMED